Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Babylon Holdings Limited stock logo
BBLN
Babylon
$0.55
$0.60
$0.46
$28.50
$14.10M2.42415,159 shsN/A
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
$0.01
+30.0%
$0.09
$0.01
$1.35
$389K2.135.40 million shs886,625 shs
Field Trip Health Ltd. stock logo
FTRP
Field Trip Health
$1.12
$2.76
$0.71
$6.41
$65.20MN/A214,681 shsN/A
UpHealth, Inc. stock logo
UPH
UpHealth
$0.73
$0.25
$3.19
$5.33M0.51121,201 shs348,700 shs
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Babylon Holdings Limited stock logo
BBLN
Babylon
0.00%0.00%0.00%0.00%-92.01%
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
-1.64%-40.00%-70.84%-96.75%-99.52%
Field Trip Health Ltd. stock logo
FTRP
Field Trip Health
0.00%0.00%0.00%0.00%+38.27%
UpHealth, Inc. stock logo
UPH
UpHealth
0.00%0.00%0.00%0.00%-81.93%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Babylon Holdings Limited stock logo
BBLN
Babylon
N/AN/AN/AN/AN/AN/AN/AN/A
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
1.3488 of 5 stars
3.52.00.00.00.61.70.6
Field Trip Health Ltd. stock logo
FTRP
Field Trip Health
N/AN/AN/AN/AN/AN/AN/AN/A
UpHealth, Inc. stock logo
UPH
UpHealth
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Babylon Holdings Limited stock logo
BBLN
Babylon
1.00
SellN/AN/A
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
3.00
Buy$6.0076,823.08% Upside
Field Trip Health Ltd. stock logo
FTRP
Field Trip Health
N/AN/AN/AN/A
UpHealth, Inc. stock logo
UPH
UpHealth
3.00
BuyN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Babylon Holdings Limited stock logo
BBLN
Babylon
$1.15B0.01N/AN/A($10.29) per share-0.05
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
N/AN/AN/AN/A($0.04) per shareN/A
Field Trip Health Ltd. stock logo
FTRP
Field Trip Health
$3.88M16.80N/AN/A$0.92 per share1.22
UpHealth, Inc. stock logo
UPH
UpHealth
$153.15M0.00N/A0.18$7.05 per share0.00

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Babylon Holdings Limited stock logo
BBLN
Babylon
-$221.45M-$23.03N/AN/A-35.54%N/A-105.06%N/A
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
-$39.76M-$1.15N/AN/AN/AN/AN/A-217.46%5/9/2024 (Estimated)
Field Trip Health Ltd. stock logo
FTRP
Field Trip Health
-$43.63M-$0.77N/AN/AN/A-1,125.12%-62.71%-47.29%N/A
UpHealth, Inc. stock logo
UPH
UpHealth
-$223M-$4.50N/AN/AN/A-49.08%12.33%3.66%N/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Babylon Holdings Limited stock logo
BBLN
Babylon
N/AN/AN/AN/AN/A
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
N/AN/AN/AN/AN/A
Field Trip Health Ltd. stock logo
FTRP
Field Trip Health
N/AN/AN/AN/AN/A
UpHealth, Inc. stock logo
UPH
UpHealth
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Babylon Holdings Limited stock logo
BBLN
Babylon
N/A
1.07
1.07
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
N/A
0.57
0.57
Field Trip Health Ltd. stock logo
FTRP
Field Trip Health
0.40
8.20
8.20
UpHealth, Inc. stock logo
UPH
UpHealth
N/A
0.13
0.13

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Babylon Holdings Limited stock logo
BBLN
Babylon
37.90%
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
34.00%
Field Trip Health Ltd. stock logo
FTRP
Field Trip Health
16.84%
UpHealth, Inc. stock logo
UPH
UpHealth
23.35%

Insider Ownership

CompanyInsider Ownership
Babylon Holdings Limited stock logo
BBLN
Babylon
38.52%
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
51.40%
Field Trip Health Ltd. stock logo
FTRP
Field Trip Health
N/A
UpHealth, Inc. stock logo
UPH
UpHealth
41.27%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Babylon Holdings Limited stock logo
BBLN
Babylon
1,89525.61 million15.75 millionNot Optionable
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
5449.86 million24.23 millionOptionable
Field Trip Health Ltd. stock logo
FTRP
Field Trip Health
10458.22 millionN/ANot Optionable
UpHealth, Inc. stock logo
UPH
UpHealth
61117.78 million10.44 millionOptionable

BTTX, FTRP, BBLN, and UPH Headlines

SourceHeadline
Calcutta HC passes interim order in Glocal caseCalcutta HC passes interim order in Glocal case
economictimes.indiatimes.com - April 16 at 7:36 PM
US-based UpHealth wins interim protection in case against Glocal Healthcare SystemsUS-based UpHealth wins interim protection in case against Glocal Healthcare Systems
telegraphindia.com - April 16 at 9:35 AM
Glocal Healthcare Systems Pvt Ltd trashes $110 million award handed out to UpHealthGlocal Healthcare Systems Pvt Ltd trashes $110 million award handed out to UpHealth
telegraphindia.com - April 8 at 2:46 AM
P&A Law Offices, DLA Piper represent UpHealth Inc in arbitration against Glocal HealthcareP&A Law Offices, DLA Piper represent UpHealth Inc in arbitration against Glocal Healthcare
barandbench.com - March 29 at 11:12 AM
Glocal Healthcare: Beyond the International Arbitration Award Lies a Complex Story of Alleged DeceptionGlocal Healthcare: Beyond the International Arbitration Award Lies a Complex Story of Alleged Deception
moneylife.in - March 27 at 8:12 AM
Case demands criminal investigation: Glocal Healthcare on ICAs order offering relief to UpHealth'Case demands criminal investigation': Glocal Healthcare on ICA's order offering relief to UpHealth
msn.com - March 23 at 6:44 AM
UpHealth wins $110.2 million in international arbitrationUpHealth wins $110.2 million in international arbitration
investing.com - March 22 at 8:43 PM
US$110.2mn International Arbitration Award Against Glocal Healthcare & Ex-SEBI Chief M Damodaran; Glocal Calls it Perverse and ex-parteUS$110.2mn International Arbitration Award Against Glocal Healthcare & Ex-SEBI Chief M Damodaran; Glocal Calls it Perverse and ex-parte
moneylife.in - March 22 at 8:43 PM
International Arbitration Court orders former SEBI chairman to pay Rs 206 croreInternational Arbitration Court orders former SEBI chairman to pay Rs 206 crore
zeebiz.com - March 22 at 10:37 AM
Ex-Sebi chief M. Damodaran asked to pay Rs 206 cr penalty for breaching contract lawsuitEx-Sebi chief M. Damodaran asked to pay Rs 206 cr penalty for breaching contract lawsuit
msn.com - March 21 at 7:33 PM
UpHealth Wins $110.2 Million In International Arbitration Against Glocal HealthcareUpHealth Wins $110.2 Million In International Arbitration Against Glocal Healthcare
ndtvprofit.com - March 21 at 7:33 PM
The International Court of Arbitration awarded UpHealth Holdings more than $110 Million in Damages in Breach of Contract Lawsuit Involving the 2020 Purchase by UpHealth of Glocal Healthcare SystemsThe International Court of Arbitration awarded UpHealth Holdings more than $110 Million in Damages in Breach of Contract Lawsuit Involving the 2020 Purchase by UpHealth of Glocal Healthcare Systems
globenewswire.com - March 20 at 5:00 PM
UpHealth completes $180m sale of telehealth translation company CloudbreakUpHealth completes $180m sale of telehealth translation company Cloudbreak
msn.com - March 19 at 9:47 PM
GTCR buys Cloudbreak HealthGTCR buys Cloudbreak Health
pehub.com - March 18 at 2:23 PM
UpHealth completes $180 million saleUpHealth completes $180 million sale
bizjournals.com - March 18 at 2:23 PM
GTCR Completes Acquisition of Cloudbreak HealthGTCR Completes Acquisition of Cloudbreak Health
finance.yahoo.com - March 18 at 9:22 AM
UpHealth Completes Sale of Cloudbreak Health at $180 Million Full Cash DealUpHealth Completes Sale of Cloudbreak Health at $180 Million Full Cash Deal
globenewswire.com - March 18 at 8:30 AM
UpHealth shareholders approve subsidiary sale for $180 millionUpHealth shareholders approve subsidiary sale for $180 million
bizjournals.com - March 6 at 7:19 PM
Shareholders of bankrupt health care firm to vote on $180 million saleShareholders of bankrupt health care firm to vote on $180 million sale
bizjournals.com - February 6 at 11:12 PM
UpHealth (OTC: UPH)UpHealth (OTC: UPH)
fool.com - January 23 at 2:19 PM
UPHLW UpHealth, Inc. WT EXP 060826UPHLW UpHealth, Inc. WT EXP 060826
seekingalpha.com - December 23 at 8:38 AM
New York Stock Exchange to Delist UpHealth, Inc.’s Common StockNew York Stock Exchange to Delist UpHealth, Inc.’s Common Stock
claytoncountyregister.com - December 11 at 7:24 PM
NYSE to Commence Delisting Proceedings Against UpHealth, Inc. (UPH)NYSE to Commence Delisting Proceedings Against UpHealth, Inc. (UPH)
financialpost.com - December 11 at 5:20 PM
UpHealth: Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of ListingUpHealth: Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing
cbonds.com - December 1 at 12:34 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Babylon logo

Babylon

NYSE:BBLN
Babylon Holdings Limited operates as a digital healthcare company. It offers end-to-end care solution that facilities through its digital health suite, virtual care, in-person medical care, and post-care offerings. The company provides Babylon Cloud and clinical services. Babylon Holdings Limited was founded in 2013 and is headquartered in Austin, Texas.
Better Therapeutics logo

Better Therapeutics

NASDAQ:BTTX
Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions. In addition, the company's clinical development candidates are intended to treat cardiometabolic diseases, including type 2 diabetes, hypertension, hyperlipidemia, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and chronic kidney disease. Its product pipeline also includes BT-002, which intends glycemic control for hypertension; BT-003 to reduce LDL cholesterol in patients with hyperlipidemia; and BT-004, which intends to explore the impact of treatment on liver health in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease. The company was founded in 2015 and is headquartered in San Francisco, California.
Field Trip Health logo

Field Trip Health

NASDAQ:FTRP
Field Trip Health Ltd. engages in the development and delivery of psychedelic- assisted therapies in North America. The company operates Field Trip Health Centres that provide psychedelic therapies; offers Field Trip Digital apps; operates Field Trip Discovery, a drug development division that develops the next generation of psychedelic molecules; and provides ketamine-assisted therapy for the treatment of depression, anxiety, addiction, and other conditions. Field Trip Health Ltd. was founded in 2008 and is headquartered in Toronto, Canada.
UpHealth logo

UpHealth

NYSE:UPH
UpHealth, Inc., together with its subsidiaries, operates as a digital health services company in the Americas, Europe, and Asia. The company operates through three segments Integrated Care Management, Virtual Care Infrastructure, and Services segments. The Integrated Care Management segment offers SyntraNet, an integrated health management platform that enables clinical and community-based care teams to share information, coordinate care, manage utilization, and improve health outcomes for individuals and populations. The Virtual Care Infrastructure segment provides the Martti platform, a digital health infrastructure that enables its partners to implement unique, private-label telehealth strategies customized to their specific needs and markets, including integrated telehealth and language access services. Its platform also offers telemedicine, such as telestroke, teleneurology, and telepsychiatry services. The Services segment offers behavioral health and pharmacy services, as well as operates HelloLyf CX platform for digital dispensary services and HelloLyf HX platform for digital hospital services; and provides diagnostic laboratory testing services. UpHealth, Inc. was founded in 2019 and is headquartered in Delray Beach, Florida.